Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Nephros Inc
Accounts Receivables
Nephros Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nephros Inc
NASDAQ:NEPH
|
Accounts Receivables
$2.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
20%
|
|
|
Whirlpool Corp
NYSE:WHR
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-7%
|
|
|
Hamilton Beach Brands Holding Co
NYSE:HBB
|
Accounts Receivables
$110.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Cricut Inc
NASDAQ:CRCT
|
Accounts Receivables
$92m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Vesync Co Ltd
HKEX:2148
|
Accounts Receivables
$183.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sharkninja Inc
NYSE:SN
|
Accounts Receivables
$1.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
See Also
What is Nephros Inc's Accounts Receivables?
Accounts Receivables
2.4m
USD
Based on the financial report for Dec 31, 2025, Nephros Inc's Accounts Receivables amounts to 2.4m USD.
What is Nephros Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
20%
Over the last year, the Accounts Receivables growth was 36%. The average annual Accounts Receivables growth rates for Nephros Inc have been 23% over the past three years , 12% over the past five years , and 20% over the past ten years .
